Open Orphan Plc (GB:HVO) has released an update.
hVIVO plc, previously known as Open Orphan plc, a leading specialist contract research organisation in the infectious and respiratory disease sector, has announced the change of its registered address to a new location in Canary Wharf, London. The company, renowned for conducting human challenge clinical trials, boasts the world’s largest commercial human challenge trial unit and offers a comprehensive range of services including drug development, clinical consultancy, and volunteer recruitment for trials.
For further insights into GB:HVO stock, check out TipRanks’ Stock Analysis page.
